• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型的 CARD11 杂合三碱基缺失导致 B 细胞扩增伴 NF-κB 和 T 细胞无能疾病。

A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease.

机构信息

Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, West Midlands, B15 2TT, UK.

Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

出版信息

J Clin Immunol. 2020 Feb;40(2):406-411. doi: 10.1007/s10875-019-00729-x. Epub 2020 Jan 2.

DOI:10.1007/s10875-019-00729-x
PMID:31897776
Abstract

Germline gain-of-function mutations in CARD11 lead to the primary immunodeficiency, B cell expansion with NF-κB, and T cell anergy (BENTA). Herein, we report the case of a girl, presenting at 2 years of age with lymphocytosis and splenomegaly in whom a novel, in-frame, three base pair deletion in CARD11 was identified resulting in the deletion of a single lysine residue (K215del) from the coiled-coil domain. In vitro functional assays demonstrated that this variant leads to a subtle increase in baseline NF-κB signaling and impaired proliferative responses following T cell receptor and mitogenic stimulation. Previously reported immunological defects associated with BENTA appear mild in our patient who is now 6 years of age; a B cell lymphocytosis and susceptibility to upper respiratory tract infections persist; however, she has broad, sustained responses to protein-polysaccharide conjugate vaccines and displays normal proliferative responses to ex vivo T cell stimulation.

摘要

CARD11 胚系获得性功能突变导致原发性免疫缺陷、B 细胞扩增伴 NF-κB 和 T 细胞无能(BENTA)。在此,我们报告了一例女孩病例,其在 2 岁时出现淋巴细胞增多和脾肿大,在 CARD11 中发现了一种新的、无框的、三个碱基对缺失,导致卷曲螺旋结构域中单个赖氨酸残基(K215del)缺失。体外功能测定表明,这种变体导致 NF-κB 信号的基线轻微增加,并在 T 细胞受体和有丝分裂原刺激后导致增殖反应受损。先前报道的与 BENTA 相关的免疫学缺陷在我们的患者中表现为轻度,该患者现已 6 岁;B 细胞淋巴细胞增多和对上呼吸道感染的易感性持续存在;然而,她对蛋白多糖结合疫苗有广泛、持续的反应,并表现出对体外 T 细胞刺激的正常增殖反应。

相似文献

1
A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease.一种新型的 CARD11 杂合三碱基缺失导致 B 细胞扩增伴 NF-κB 和 T 细胞无能疾病。
J Clin Immunol. 2020 Feb;40(2):406-411. doi: 10.1007/s10875-019-00729-x. Epub 2020 Jan 2.
2
Identification and Characterization of a Germline Mutation in CARD11 From a Chinese Case of B Cell Expansion With NF-κB and T Cell Anergy.CARD11 种系突变导致的 B 细胞过度增殖伴 NF-κB 和 T 细胞无能:一例中国患者的鉴定与特征描述。
Front Immunol. 2021 Sep 7;12:676386. doi: 10.3389/fimmu.2021.676386. eCollection 2021.
3
A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review.中国一例 B 细胞扩增伴 NF-κB 和 T 细胞无能(BENTA)患者的新型 CARD11 种系突变及文献复习。
Front Immunol. 2022 Sep 20;13:943027. doi: 10.3389/fimmu.2022.943027. eCollection 2022.
4
A Unique Heterozygous Mutation Combines Pathogenic Features of Both Gain- and Loss-of-Function Patients in a Four-Generation Family.一个独特的杂合突变在一个四代家族中结合了 gain-of-function 和 loss-of-function 患者的致病性特征。
Front Immunol. 2018 Dec 12;9:2944. doi: 10.3389/fimmu.2018.02944. eCollection 2018.
5
Germline CARD11 Mutation in a Patient with Severe Congenital B Cell Lymphocytosis.一名患有严重先天性B细胞淋巴细胞增多症患者的种系CARD11突变
J Clin Immunol. 2015 Jan;35(1):32-46. doi: 10.1007/s10875-014-0106-4. Epub 2014 Oct 29.
6
A familial case of B-cell expansion with NF-κB and T-cell anergy caused by a G123D heterozygous missense mutation in the CARD11 gene.CARD11 基因 G123D 杂合错义突变导致 NF-κB 驱动的 B 细胞扩增和 T 细胞无能的家族性病例。
Pediatr Blood Cancer. 2022 Dec;69(12):e29941. doi: 10.1002/pbc.29941. Epub 2022 Sep 21.
7
Clinical, Immunological, and Molecular Findings in Four Cases of B Cell Expansion With NF-κB and T Cell Anergy Disease for the First Time From India.首次从印度发现的 4 例 B 细胞扩增伴 NF-κB 和 T 细胞无反应疾病的临床、免疫学和分子研究结果。
Front Immunol. 2018 Jun 14;9:1049. doi: 10.3389/fimmu.2018.01049. eCollection 2018.
8
Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.新型胚系 CARD11 突变导致先天性 B 细胞淋巴细胞增多症。
J Exp Med. 2012 Nov 19;209(12):2247-61. doi: 10.1084/jem.20120831. Epub 2012 Nov 5.
9
Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease.B 细胞扩增伴 NF-κB 和 T 细胞无能疾病中,EB 病毒感染的控制受损。
Front Immunol. 2018 Feb 8;9:198. doi: 10.3389/fimmu.2018.00198. eCollection 2018.
10
Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience.15 例杂合性 CARD11 相关疾病患者的谱扩展、家系内多样性和治疗挑战:单中心经验。
Front Immunol. 2022 Nov 3;13:1020927. doi: 10.3389/fimmu.2022.1020927. eCollection 2022.

引用本文的文献

1
From syndromic clues to diagnosis: understanding CARD11-driven disorders.从综合征线索到诊断:了解CARD11驱动的疾病。
Front Immunol. 2025 Jun 23;16:1626065. doi: 10.3389/fimmu.2025.1626065. eCollection 2025.
2
Successful Treatment with Sirolimus of a Patient with a Novel CARD11 Germline Mutation in B-Cell Expansion with Nuclear Factor Kappa B and T-Cell Anergy: Case Report and Literature Review.西罗莫司成功治疗一例具有新型CARD11种系突变的患者:核因子κB介导的B细胞扩增及T细胞无能的病例报告与文献综述
J Clin Immunol. 2025 Feb 25;45(1):78. doi: 10.1007/s10875-025-01872-4.
3
MDA5 gain-of-function associated with a Glu794del mutation.

本文引用的文献

1
A Unique Heterozygous Mutation Combines Pathogenic Features of Both Gain- and Loss-of-Function Patients in a Four-Generation Family.一个独特的杂合突变在一个四代家族中结合了 gain-of-function 和 loss-of-function 患者的致病性特征。
Front Immunol. 2018 Dec 12;9:2944. doi: 10.3389/fimmu.2018.02944. eCollection 2018.
2
Clinical, Immunological, and Molecular Findings in Four Cases of B Cell Expansion With NF-κB and T Cell Anergy Disease for the First Time From India.首次从印度发现的 4 例 B 细胞扩增伴 NF-κB 和 T 细胞无反应疾病的临床、免疫学和分子研究结果。
Front Immunol. 2018 Jun 14;9:1049. doi: 10.3389/fimmu.2018.01049. eCollection 2018.
3
与Glu794del突变相关的MDA5功能获得
J Clin Immunol. 2024 Oct 2;45(1):20. doi: 10.1007/s10875-024-01813-7.
4
Inborn errors of human B cell development, differentiation, and function.人类 B 细胞发育、分化和功能的先天缺陷。
J Exp Med. 2023 Jul 3;220(7). doi: 10.1084/jem.20221105. Epub 2023 Jun 5.
5
Skin manifestations of inborn errors of NF-κB.核因子κB先天性缺陷的皮肤表现
Front Pediatr. 2023 Jan 17;10:1098426. doi: 10.3389/fped.2022.1098426. eCollection 2022.
6
Mistuned NF-κB signaling in lymphocytes: lessons from relevant inborn errors of immunity.淋巴细胞中 NF-κB 信号失调:相关先天性免疫缺陷的启示。
Clin Exp Immunol. 2023 Apr 25;212(2):117-128. doi: 10.1093/cei/uxad006.
7
Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience.15 例杂合性 CARD11 相关疾病患者的谱扩展、家系内多样性和治疗挑战:单中心经验。
Front Immunol. 2022 Nov 3;13:1020927. doi: 10.3389/fimmu.2022.1020927. eCollection 2022.
8
A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review.中国一例 B 细胞扩增伴 NF-κB 和 T 细胞无能(BENTA)患者的新型 CARD11 种系突变及文献复习。
Front Immunol. 2022 Sep 20;13:943027. doi: 10.3389/fimmu.2022.943027. eCollection 2022.
9
Defining and targeting patterns of T cell dysfunction in inborn errors of immunity.定义和靶向免疫先天缺陷中 T 细胞功能障碍的模式。
Front Immunol. 2022 Sep 14;13:932715. doi: 10.3389/fimmu.2022.932715. eCollection 2022.
10
Identification and Characterization of a Germline Mutation in CARD11 From a Chinese Case of B Cell Expansion With NF-κB and T Cell Anergy.CARD11 种系突变导致的 B 细胞过度增殖伴 NF-κB 和 T 细胞无能:一例中国患者的鉴定与特征描述。
Front Immunol. 2021 Sep 7;12:676386. doi: 10.3389/fimmu.2021.676386. eCollection 2021.
Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease.
B 细胞扩增伴 NF-κB 和 T 细胞无能疾病中,EB 病毒感染的控制受损。
Front Immunol. 2018 Feb 8;9:198. doi: 10.3389/fimmu.2018.00198. eCollection 2018.
4
Intrinsic Plasma Cell Differentiation Defects in B Cell Expansion with NF-κB and T Cell Anergy Patient B Cells.B细胞因NF-κB和T细胞无能患者B细胞而扩张时的内在浆细胞分化缺陷。
Front Immunol. 2017 Aug 2;8:913. doi: 10.3389/fimmu.2017.00913. eCollection 2017.
5
Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutation.患有CARD11 C49Y突变的患者出现轻度B细胞淋巴细胞增多症。
J Allergy Clin Immunol. 2015 Sep;136(3):819-821.e1. doi: 10.1016/j.jaci.2015.03.008. Epub 2015 Apr 28.
6
Germline CARD11 Mutation in a Patient with Severe Congenital B Cell Lymphocytosis.一名患有严重先天性B细胞淋巴细胞增多症患者的种系CARD11突变
J Clin Immunol. 2015 Jan;35(1):32-46. doi: 10.1007/s10875-014-0106-4. Epub 2014 Oct 29.
7
The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.CARD11-BCL10-MALT1(CBM)信号体复合物:步入人类原发性免疫缺陷的聚光灯下。
J Allergy Clin Immunol. 2014 Aug;134(2):276-84. doi: 10.1016/j.jaci.2014.06.015.
8
Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation.炎症 T 细胞反应依赖于氨基酸转运蛋白 ASCT2 促进谷氨酰胺摄取和 mTORC1 激酶激活。
Immunity. 2014 May 15;40(5):692-705. doi: 10.1016/j.immuni.2014.04.007. Epub 2014 May 1.
9
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.与慢性淋巴细胞白血病向里氏综合征转化相关的遗传病变。
J Exp Med. 2013 Oct 21;210(11):2273-88. doi: 10.1084/jem.20131448. Epub 2013 Oct 14.
10
A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival.一种定量信号筛选方法鉴定了 CARD 和 LATCH 结构域中的 CARD11 突变,这些突变诱导 Bcl10 泛素化和人淋巴瘤细胞存活。
Mol Cell Biol. 2013 Jan;33(2):429-43. doi: 10.1128/MCB.00850-12. Epub 2012 Nov 12.